In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Royal Philips

https://www.philips.com/global

Latest From Royal Philips

News We’re Watching: Medtronic To Buy EOFLow, Neuralink Cleared For Human Trials, NICE Backs Genetic Tests

Bookmark
  • News
By Brian Bossetta, Reed Miller, Ashley Yeo and Eliza Slawther

This week, Medtronic said it would pay $738m for insulin patch firm EOFlow; Neuralink got an FDA OK for first-in-human trials; and UK agency NICE backed genetic tests for stroke patients and digital therapeutics for mental health conditions.

Regulation Commercial

Leadership Report: More AI To Compensate For Healthcare Staff Shortages

Bookmark
  • Analysis
By Ashley Yeo

Healthcare leaders are increasing their use of virtual care for patients and are more ready to adopt artificial intelligence for critical decision support and operational efficiency, says Royal Philips’ Future Health Index 2023.

Leadership Artificial Intelligence

The E in ESG: Philips Drives For Science-Based Targets In Carbon Zero Challenge

Bookmark
  • Interviews
By Ashley Yeo

With a product mix that includes high energy consumption imaging, capital equipment and personal health care, Philips has a unique spectrum of challenges in driving low carbon health care. Nevertheless, it has set the bar high in environmental sustainability goals, and is pressing suppliers to follow its lead.

Leadership Sustainability

Extraordinary Times Call For Exceptional Response From Philips’ Connected Care Chief

Bookmark
  • Analysis
By Ashley Yeo

Roy Jakobs was appointed internally to head connected care at Philips on 28 January, shortly before COVID-19 forced the first of many lockdowns around the world. The disruption prompted a rapid rethink of priorities, which has shown opportunities for lasting health care system change.

Leadership Coronavirus COVID-19
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
  • Other Names / Subsidiaries
    • AngioScore, Inc.
    • AtheroMed
    • Axsun Technologies
    • BioTelemetry, Inc.
    • Cardiologs Technologies SAS
    • CardioProlific Inc.
    • Crux Biomedica
    • Dynalite
    • Electrical Geodesics, Inc.
    • EndoSonics Corp.
    • Forcare
    • Gaggia
    • Intact Vascular Inc.
    • Kensey Nash Corp's Endovascular business unit
    • Koninklijke Philips
    • Magnavox
    • Medumo, Inc
    • Mini-Mitter
    • JOMED
    • Philips
    • PolyGram
    • Pye Ltd.
    • Remote Diagnostic Technologies LLC
    • Respironics, Inc.
    • Royal Philips
    • Saeco
    • Shenzhen Goldway Industrial
    • Spectranetics Corporation
    • Sync-RX
    • TomTec Imaging Systems GmbH
    • Upstream Peripheral Technologies, Ltd.
    • VitalHealth
    • Volcano Corporation
    • Xhale Assurance, Inc.
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By